Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PDE6D | O43924 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12190900 | 0.94 | RXFP1 (0.50) | RXFP1TP53GPR3LMNAMAPT | |
| SCHEMBL2498455 | 0.88 | RXFP1 (0.53) | RXFP1MGLLTP53GPR3LMNA | |
| SCHEMBL20391572 | 0.85 | RXFP1 (0.43) | RXFP1FAAHMGLLTP53GPR3 | |
| SCHEMBL20275927 | 0.85 | LMNA (0.58) | RXFP1MGLLTP53GPR3LMNA | |
| SCHEMBL2497311 | 0.85 | RXFP1 (0.43) | RXFP1MGLLTP53GPR3LMNA | |
| SCHEMBL18267499 | 0.84 | BRCA1 (0.42) | GPR3LMNAMAPTTHRBPDE6D | |
| SCHEMBL20383523 | 0.84 | BRCA1 (0.48) | MEN1KMT2AMAOA | |
| SCHEMBL12190855 | 0.83 | RXFP1 (0.48) | RXFP1TP53GPR3LMNAMAPT | |
| SCHEMBL12349299 | 0.83 | RXFP1 (0.42) | RXFP1TP53GPR3LMNAMAPT | |
| SCHEMBL17955145 | 0.83 | RXFP1 (0.42) | RXFP1TP53GPR3LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817806-B1 | PHENOTHAZINES-S-OXIDES AND S,S-DIOXIDES AS hole and excitonblockers for OLEDs | BASF SE (DE) | 2014-07-30 | — | — | EP | disclosed |
| US-8029919-B2 | Phenothiazines, S-oxides, and S,S-dioxides as well as phenoxazines as emitters for OLEDs | BASF AKTIENGESELLSCHAFT (DE) | 2011-10-04 | — | — | US | disclosed |
| US-8029919-B2 | Phenothiazines, S-oxides, and S,S-dioxides as well as phenoxazines as emitters for OLEDs | BASF AKTIENGESELLSCHAFT (DE) | 2011-10-04 | — | — | US | disclosed |
| US-20100308714-A1 | Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds | BASF AKTIENGESELLSCHAFT (DE) | 2010-12-09 | — | — | US | disclosed |
| US-20100308714-A1 | Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds | BASF AKTIENGESELLSCHAFT (DE) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100308714-A1 | Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds | PPOX, SMOX, SORD | RXFP1 4687/4885FAAH 3754/4885MGLL 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.